The authors sought to evaluate whether a sustained systemic inflammatory response was associated with shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage.
A retrospective analysis of 193 consecutive patients with aneurysmal subarachnoid hemorrhage was performed. Management of hydrocephalus followed a stepwise algorithm to determine the need for external CSF drainage and subsequent shunt placement. Systemic inflammatory response syndrome (SIRS) data were collected for all patients during the first 7 days of hospitalization. Patients who met the SIRS criteria every day for the first 7 days of hospitalization were considered as having a sustained SIRS. Univariate and multivariate regression analyses were used to determine predictors of shunt dependence.
Sixteen percent of patients required shunt placement. Sustained SIRS was observed in 35% of shunt-dependent patients compared to 14% in non–shunt-dependent patients (p = 0.004). On multivariate logistic regression, female sex (OR 0.35, 95% CI 0.142–0.885), moderate to severe vasospasm (OR 3.78, 95% CI 1.333–10.745), acute hydrocephalus (OR 21.39, 95% CI 2.260–202.417), and sustained SIRS (OR 2.94, 95% CI 1.125–7.689) were significantly associated with shunt dependence after aneurysmal subarachnoid hemorrhage. Receiver operating characteristic analysis revealed an area under the curve of 0.83 for the final regression model.
Sustained SIRS was a predictor of shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage even after adjustment for potential confounding variables in a multivariate logistic regression model.
ABBREVIATIONSAUC = area under the curve; CTA = CT angiography; DND = delayed neurological deficit; DSA = digital subtraction angiography; EVD = external ventricular drain; MFS = modified Fisher scale; NF = nuclear factor; ROC = receiver operating characteristic; SIRS = systemic inflammatory response syndrome; TGF = transforming growth factor; WFNS = World Federation of Neurosurgical Societies.
ConnollyESJrRabinsteinAACarhuapomaJRDerdeynCPDionJHigashidaRT: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke43:1711–17372012
GruberARösslerKGraningerWDonnerAIllievichMUCzechT: Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol12:297–3062000
GüresirESchussPBorgerVVatterH: Experimental subarachnoid hemorrhage: double cisterna magna injection rat model—assessment of delayed pathological effects of cerebral vasospasm. Transl Stroke Res6:242–2512015
HirashimaYNakamuraSEndoSKuwayamaNNaruseYTakakuA: Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res22:1249–12551997
HootonTMBradleySFCardenasDDColganRGeerlingsSERiceJC: Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis50:625–6632010
KalilACMeterskyMLKlompasMMuscedereJSweeneyDAPalmerLB: Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis63:e61–e1112016
KanatATurkmenogluOAydinMDYolasCAydinNGursanN: Toward changing of the pathophysiologic basis of acute hydrocephalus after subarachnoid hemorrhage: a preliminary experimental study. World Neurosurg80:390–3952013
LittleASZabramskiJMPetersonMGoslarPWWaitSDAlbuquerqueFC: Ventriculoperitoneal shunting after aneurysmal subarachnoid hemorrhage: analysis of the indications, complications, and outcome with a focus on patients with borderline ventriculomegaly. Neurosurgery62:618–6272008
SaliouGParadotGGondryCBouzerarRLehmannPMeyersME: A phase-contrast MRI study of acute and chronic hydrodynamic alterations after hydrocephalus induced by subarachnoid hemorrhage. J Neuroimaging22:343–3502012
TamAKIlodigweDMoccoJMayerSKassellNRuefenachtD: Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database. Neurocrit Care13:182–1892010
TeasdaleGMDrakeCGHuntWKassellNSanoKPertuisetB: A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry51:14571988
TunkelARHasbunRBhimrajAByersKKaplanSLScheldWM: 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis64:e34–e652017
WeidauerSLanfermannHRaabeAZanellaFSeifertVBeckJ: Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke38:1831–18362007
ZaidiHAMontoureAElhadiANakajiPMcDougallCGAlbuquerqueFC: Long-term functional outcomes and predictors of shunt-dependent hydrocephalus after treatment of ruptured intracranial aneurysms in the BRAT trial: revisiting the clip vs coil debate. Neurosurgery76:608–6142015